Milind Phadnis

18PUBLICATIONS
42CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Stochastic analysis and modellingChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 24, 2026
Optimizing rare neurological disease trials: Bayesian frameworks and hierarchical models for improved efficiency in clinical trial design.

|Feb 07, 2025
Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial.

Qamar J Khan, Colleen Bohnenkamp, Taylor E Monson

|Jan 14, 2025
ABO incompatibility and component irradiation are independently associated with platelet transfusion reaction rate.

Keenan O Hogan, Geethanjalee Mudunkotuwa, Milind Phadnis

|Aug 18, 2024
Sample Size Reestimation in Stochastic Curtailment Tests With Time-to-Events Outcome in the Case of Nonproportional Hazards Utilizing Two Weibull Distributions With Unknown Shape Parameters.

Palash Sharma, Milind A Phadnis

|Aug 14, 2023
Stochastic curtailment tests for phase II trial with time-to-event outcome using the concept of relative time in the case of non-proportional hazards.

Palash Sharma, Milind A Phadnis

|Aug 07, 2023
Sample size reestimation and Bayesian predictive probability for single-arm clinical trials with a time-to-event endpoint using Weibull distribution with unknown shape parameter.

Muhammad Waleed, Jianghua He, Milind A Phadnis

Pageof 3

Frequent Collaborators

3 joint publications

Mohammed M Alshehri

3 joint publications

Aqeel M Alenazi

3 joint publications

Shaima A Alothman

3 joint publications

Jason L Rucker